$533.65
-8.53-1.57%
Last update: Nov 3, 6:58 PM
Chemed Corp
CHENYSE
Chemed (CHE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Chemed (CHE) last issued guidance on October 27, 2026 for fiscal year 2026. The company guided revenue in the range of for the period.
Compared to prior guidance, Chemed raised its EPS outlook from a previous range of $24 - $24.75.
Chemed has issued 13 guidance updates between February 23, 2023 and July 28, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.33 | $5.50 | $5.21 | $6.85 |
| Actual | $6.75 | $6.06 | $5.65 | $6.42 |
| Surprise | +6.64% | +10.2% | +8.45% | -6.28% |
| Revenue | ||||
| Estimate | $684.0M | $664.2M | $648.0M | $657.9M |
| Actual | $690.9M | $673.3M | $657.5M | $639.3M |
| Surprise | +1.01% | +1.36% | +1.46% | -2.82% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $7.27 | $6.07 | $6.19 | $6.49 |
| Revenue | ||||
| Consensus | $711.6M | $711.6M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $6.75 | $6.33 | 6.64 % |
| Q2 | Jul 28, 2026 | $6.06 | $5.50 | 10.2 % |
| Q1 | Apr 23, 2026 | $5.65 | $5.21 | 8.45 % |
| Q4 | Feb 25, 2026 | $6.42 | $6.85 | -6.28 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $690.94M | $684.04M | 1.01 % |
| Q2 | Jul 28, 2026 | $673.25M | $664.21M | 1.36 % |
| Q1 | Apr 23, 2026 | $657.51M | $648.04M | 1.46 % |
| Q4 | Feb 25, 2026 | $639.34M | $657.88M | -2.82 % |
